1,500
Participants
Start Date
November 30, 2015
Primary Completion Date
April 30, 2017
Study Completion Date
June 30, 2017
BRV-PV Lot A + DPT-HepB-Hib + OPV
Dose 1: 6-8 weeks, Dose 2: 10 week, Dose 3: 14 week
BRV-PV Lot B + DPT-HepB-Hib + OPV
Dose 1: 6-8 weeks, Dose 2: 10 week, Dose 3: 14 week
BRV-PV Lot C + DPT-HepB-Hib + OPV
Dose 1: 6-8 weeks, Dose 2: 10 week, Dose 3: 14 week
ROTARIX + DPT-HepB-Hib + OPV
Dose 1: 6-8 weeks, Dose 2: 10 week, Dose 3: 14 week (Third dose-Placebo)
T. N. Medical College and B. Y. L. Nair Charitable, Mumbai
Seth G S Medical College & KEM Hospital, Mumbai
Bharati Vidyapeeth Medical College and Hospital, Pune
KEM Hospital and Research Centre, Vadu, Pune
Gandhi Medical College and Gandhi Hospital, Hyderabad
King George Hospital, Visakhapatnam
JSS Medical College and Hospital, Mysore
Sri Ramachandra Medical Centre, Chennai
Institute of Child Health, Kolkata
Maulana Azad Medical College, New Delhi
PATH
OTHER
Serum Institute of India Pvt. Ltd.
INDUSTRY